Search

everythinglearnresearchcommunity

for

Search:↓

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Finasteride improves heart function and balance in aging and obese male rats by reducing oxidative stress.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Finasteride shows promise for female hair loss, but more research needed.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Consider benefits and risks of new alopecia treatments for safety.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Post-finasteride syndrome's existence is uncertain; more research needed.

Oregano extract helps fix testis and sperm damage caused by finasteride.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Jute leaves may help reduce DHT levels, potentially aiding in conditions like hair loss and prostate issues.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Finasteride reduces corpus cavernosum weight but doesn't affect erectile response in rats.

Combination therapies work better than single treatments for hair loss.

LLLT is a safe, promising hair loss treatment, but more research needed.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.